{
  "issued_date": "2012-09-20", 
  "original_url": "http://www.mhra.gov.uk/Publications/Safetywarnings/DrugAlerts/CON185158", 
  "doc_details": {
    "Type": "Drug Alert", 
    "Series No": "EL (12) A/31", 
    "Audience": "Healthcare professionals", 
    "Published": "", 
    "Format": "Electronic", 
    "Size": "A4", 
    "Pages": "2", 
    "Price": "Free", 
    "ISBN/ISSN": "", 
    "Author": "", 
    "Copyright": "Crown"
  }, 
  "_assets": [
    {
      "content_type": "application/pdf", 
      "title": " Class 4 Drug Alert (caution in use): Diflucan powder for oral suspension (10 mg/ml and 40 mg/ml) - Pfizer Limited - EL (12)A/31 (177Kb)", 
      "assetid": 0, 
      "original_url": "http://www.mhra.gov.uk/home/groups/is-md/documents/websiteresources/con185161.pdf", 
      "filename": "downloads/5a79fc56bfa90c7a22acccc252d494296eb81b98/con185161.pdf", 
      "original_filename": "con185161.pdf"
    }
  ], 
  "body": "## DRUG ALERT\n\nCLASS 4 MEDICINES DEFECT INFORMATION\n\nCAUTION IN USE\n\n  \n\n\nDistribute to\u00a0pharmacy level  \n  \n20 September 2012  |   |  EL (12) A/31  |   |  Our ref:\u00a0 MDR 14-09/12   | \n\n* * *\n\nDear Healthcare Professional,\n\nPfizer Limited\n\nDiflucan 10 mg/ml powder for oral suspension \u00a0\u00a0PL 00057/0343\n\nDiflucan 40mg/ml powder for oral suspension \u00a0\u00a0PL 00057/0344\n\n(Fluconazole)  \n  \nPfizer Limited has recently amended the labels and patient information leaflet (PIL) for the above products. They have informed us that there may be some confusion resulting from the new packaging, as follows:  \n  \n  * The PIL, which is common to both strengths, provides reconstitution instructions for a 175ml bottle. Pharmacists are asked to disregard these instructions as the 175ml presentation is not available in the UK. The only pack size in the UK is the 60ml bottle and instructions for reconstitution are provided in the PIL in the section containing information intended for medical or healthcare professionals  \n  * For Diflucan 40mg/ml, batch A233306, the level mark on the label, which is referred to in the reconstitution instructions in the PIL, is missing. Pharmacists are asked to ensure that 24ml water is added. This produces 35ml of useable suspension.  \n  \n  \nTo ensure continuity of supply, distribution of affected stock will continue and it will be necessary to release further batches. \u00a0Steps are being taken to remedy this situation as quickly as possible, but it may be several months before the issue is resolved.\n\nFor further information, please contact Pfizer Medical Information team on 01304 616161.\n\nRecipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. Primary Care Trusts are asked to forward this to relevant clinics and to General Practitioners and Community Pharmacists for information.\n\nYours faithfully\n\nAlison Bunce  \nPharmaceutical Assessor, DMRC\n\nMHRA Distribution (further recipients by cascade):  Regional contacts for NHS Trusts and provider units  \nChief pharmacists: England, Scotland, Wales, Northern Ireland  \nPrison health policy unit (DH)  \nChief pharmacists: \u00a0Jersey, Guernsey, Alderney, Sark, Isle of Man, Gibraltar  \nSpecial hospitals  \nHealthcare commission for distribution to independent health care establishments  \nPrimary care trusts (England) \n\n### Download documents:  \n  \n  * [ASSET_TAG](#ASSET0)\n", 
  "raw_html": "<div class=\"inner\">          \r\n\t\t\t\t<a name=\"main\"></a>\r\n\t\t\t\t\r\n\t\t\t\t<div class=\"title\">\r\n\t\t\t\t\t<h2>DRUG ALERT</h2>\r\n\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element14)-->\r\n\t\t\t\t\t<p>CLASS 4 MEDICINES DEFECT INFORMATION</p>\r\n\t\t\t\t\t<!--SS_END_ELEMENT(region1_element14)-->\r\n\t\t\t\t</div>\r\n\t\t\t\t\r\n\t\t\t\t<div class=\"drugalertdetails\">\r\n\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element15)-->\r\n\t\t\t\t\t<p>CAUTION IN USE</p>\r\n\t\t\t\t\t<!--SS_END_ELEMENT(region1_element15)-->\r\n\t\t\t\t\t<br>\r\n\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element16)-->\r\n\t\t\t\t\t<p>Distribute to&#160;pharmacy level</p>\r\n\t\t\t\t\t<!--SS_END_ELEMENT(region1_element16)-->\r\n\t\t\t\r\n\t\t\t\t\t<table id=\"dateref\">\r\n\t\t\t\t\t\t<tr>\r\n\t\t\t\t\t\t\t<td align=\"left\">\r\n\t\t\t\t\t\t\t\r\n\r\n\t\t\t\t\t\t\t20 September 2012\r\n\t\t\t\t\t\t\t</td>\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t<td>\r\n\t\t\t\t\t\t\tEL (12) A/31\r\n\t\t\t\t\t\t\t</td>\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t<td align=\"right\">\r\n\t\t\t\t\t\t\t\tOur ref:&#160;\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element17)-->\r\n\t\t\t\t\t\t\t\t MDR 14-09/12 \r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element17)-->\r\n\t\t\t\t\t\t\t</td>\r\n\t\t\t\t\t\t</tr>\r\n\t\t\t\t\t</table>\r\n\t\t\t\t</div>\r\n\t\t\t\t<hr>\t\t\t\t\r\n          \t\t<!--SS_BEGIN_ELEMENT(region1_element12)-->\r\n          \t\t<!--SS_END_ELEMENT(region1_element12)--> \r\n          \t\t\r\n          \t\t \r\n          \t\t\r\n          \t\t<p>Dear Healthcare Professional,</p>\r\n\r\n\t\t\t\t<div class=\"druginfo\">\r\n\t\t\t\t\t<div class=\"left\">\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t<p>\r\n\t\t\t\t\t\t\t<span>Pfizer Limited</span>\r\n\t\t\t\t\t\t</p>\r\n\t\t\t\t\t\t\t\t\t\t\r\n          \t\t          \t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t</div>\r\n\t\t\t\t\t\r\n\t\t\t\t\t<div class=\"right\">\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t</div>\t\r\n\t\t\t\t</div>\t\t\t\t\r\n          \t\t\r\n\t\t\t\t<!-- SS_BEGIN_SNIPPET(fragment8,navigation_controls)-->\r\n\t\t\t\t<!-- only show the publication navigation controls if there is more than one page to the publication -->\r\n\t\t\t\r\n\t\t\t\t<!-- SS_END_SNIPPET(fragment8,navigation_controls)-->\r\n \t\t\r\n\t\t\t\t<!-- SS_BEGIN_SNIPPET(region1_element2,paged_publication)-->\r\n        \t\t<!-- <br>SS_DATAFILE: CON185158 -->\r\n\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<p></p><p><span>Diflucan 10 mg/ml powder for oral suspension &#160;&#160;PL 00057/0343</span></p>\n\n<p><span>Diflucan 40mg/ml powder for oral suspension &#160;&#160;PL 00057/0344</span></p>\n\n<p><span>(Fluconazole)<br>\n<br>\n</span>Pfizer Limited has recently amended the labels and patient information leaflet (PIL) for the above products. They have informed us that there may be some confusion resulting from the new packaging, as follows:</p>\n\n<ul>\n<li>The PIL, which is common to both strengths, provides reconstitution instructions for a 175ml bottle. Pharmacists are asked to disregard these instructions as the 175ml presentation is not available in the UK. The only pack size in the UK is the 60ml bottle and instructions for reconstitution are provided in the PIL in the section containing information intended for medical or healthcare professionals</li>\n\n<li>For Diflucan 40mg/ml, batch A233306, the level mark on the label, which is referred to in the reconstitution instructions in the PIL, is missing. Pharmacists are asked to ensure that 24ml water is added. This produces 35ml of useable suspension.</li>\n</ul>\n\n<p><br>\nTo ensure continuity of supply, distribution of affected stock will continue and it will be necessary to release further batches. &#160;Steps are being taken to remedy this situation as quickly as possible, but it may be several months before the issue is resolved.</p>\n\n<p>For further information, please contact Pfizer Medical Information team on 01304 616161.</p>\n\n<p>Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. Primary Care Trusts are asked to forward this to relevant clinics and to General Practitioners and Community Pharmacists for information.</p>\n\n<p>Yours faithfully</p>\n\n<p>Alison Bunce<br>\nPharmaceutical Assessor, DMRC</p>\r\n\r\n\t\t\t\r\n        \t\t<!-- SS_END_SNIPPET(region1_element2,paged_publication)-->\r\n        \t\t\r\n        \t\tMHRA Distribution (further recipients by cascade):\r\n        \t\t\r\n        \t\t <!--SS_BEGIN_ELEMENT(region1_element18)-->\r\n        \t\tRegional contacts for NHS Trusts and provider units<br>\nChief pharmacists: England, Scotland, Wales, Northern Ireland<br>\nPrison health policy unit (DH)<br>\nChief pharmacists: &#160;Jersey, Guernsey, Alderney, Sark, Isle of Man, Gibraltar<br>\nSpecial hospitals<br>\nHealthcare commission for distribution to independent health care establishments<br>\nPrimary care trusts (England)\r\n        \t\t<!--SS_END_ELEMENT(region1_element18)-->\r\n \t\t\r\n\t\t\t\t<!-- SS_BEGIN_SNIPPET(region1_element3,static_pdf_list)-->\r\n        \t\t<!-- the xmlListTag variable is used by the searchDocsByContentIdList include to map the name of the XML node which contains the content id -->\r\n<!--perform the search -->\r\n\t\r\n\t<!-- <br>root: Content/AssociatedContent -->\r\n\t<!-- <br>ssFragmentInstanceId: region1_element3\t -->\r\n\t<!-- <br>SS_DATAFILE: CON185158 -->\r\n\t<!-- <br>xmlListTag: ContentId\t -->\r\n\t<!-- <br>XPATH: CON185158/Content/AssociatedContent/ContentId\t -->\r\n\r\n\t<!-- xmlListTag variable should be the name of the xml node which contains a contentid.  there should be a lis of these in the XML -->\r\n\t<!-- <br>strNumRecords: 1 -->\r\n\t<!-- <br>nNumRecords: 1 -->\r\n\r\n\t\t\t<!-- using the content ID above, get the docment from conetent server-->\r\n\r\n\t\t\t\r\n\r\n\t\t<!--  dDocName <matches>`CON185161` -->\r\n\t\t\r\n<div id=\"downloadArea\">\r\n\t<h3>Download documents:</h3>\r\n\t<ul>\r\n\t\t<!-- the SearchResults will have been initialised by the call to searchDocsByContentIdList above-->\r\n\t\t\t\r\n\t\t\t\t<li>\r\n\r\n\t\t\t\t\t\t<a href=\"#ASSET0\">ASSET_TAG</a>\r\n\t\t\t\t</li>\r\n\t</ul>\r\n\t<div class=\"clearing\"><!--  --></div>\r\n\t<!--<p><a class=\"doubleArrow\" target=\"new\" href=\"http://www.adobe.com/products/acrobat/readstep2.html\">Download Acrobat Reader for free</a></p>\r\n\t<p><a class=\"doubleArrow\" target=\"new\" href=\"http://www.adobe.com/products/acrobat/access_onlinetools.html\">Adobe text conversion tools</a></p>-->\r\n</div>\r\n\t\t\t\r\n        \t\t<!-- SS_END_SNIPPET(region1_element3,static_pdf_list)-->\r\n \t\t\r\n\t\t\t\t<!-- SS_BEGIN_CLOSEREGIONMARKER(region1)-->\r\n        \t\t\r\n        \t\t<!-- SS_END_CLOSEREGIONMARKER(region1)-->\r\n\t\t\t</div>\r\n\t\t", 
  "title": "Class 4 Drug Alert (caution in use): Diflucan powder for oral suspension (10 mg/ml and 40 mg/ml) - Pfizer Limited - EL (12)A/31", 
  "alert_type": [
    "drugs"
  ], 
  "medical_specialism": [
    "pharmacy"
  ]
}